The Immunoenhancing Property of a Dietary Casein Phosphopeptide Preparation in Mice
The effect on serum and intestinal IgG or IgA production of a dietary casein phosphopeptide preparation, CPP-III, mainly consisting of residues 1–32 of bovine alpha s2-casein and residues 1–28 of bovine beta-casein, was investigated in mice. No significant difference was seen in body weight gained between mice fed a CPP-III-added diet (a mixture of 0.1 to 1.0 g CPP-III and 24.9 to 24.0 g ovalbumin as protein sources in 100 g diet) and mice fed a control diet (25.0 g ovalbumin in 100 g diet). Mice fed CPP-III-added diets exhibited a similar serum IgG response towards beta-lactoglobulin injected peritoneally and ovalbumin ingested orally to those fed the control diet. In contrast, the level of serum IgA towards the proteins showed a rising tendency in mice fed CPP-III-added diets compared with those fed the control diet. The difference between the control diet group and CPP-III-added diet groups was often statistically significant. Moreover, the intestinal antigen-specific IgA and total IgA in some mice fed the CPP-III-added diet were significantly higher than those fed the control diet. The present results suggest that oral use of the casein phosphopeptide is beneficial to the enhancement of mucosal immunity.
No Reference information available - sign in for access.
No Citation information available - sign in for access.
No Supplementary Data.
No Article Media
Document Type: Research Article
Publication date: June 1, 2000